Skip to main content

Advertisement

Download PDF

What kind of systematic review should I conduct? A proposed typology and guidance for systematic reviewers in the medical and health sciences

BMC Medical Research Methodology volume 18, Article number: 5 (2018) Cite this article

Abstract

Background

Systematic reviews have been considered as the pillar on which evidence-based healthcare rests. Systematic review methodology has evolved and been modified over the years to accommodate the range of questions that may arise in the health and medical sciences. This paper explores a concept still rarely considered by novice authors and in the literature: determining the type of systematic review to undertake based on a research question or priority.

Results

Within the framework of the evidence-based healthcare paradigm, defining the question and type of systematic review to conduct is a pivotal first step that will guide the rest of the process and has the potential to impact on other aspects of the evidence-based healthcare cycle (evidence generation, transfer and implementation). It is something that novice reviewers (and others not familiar with the range of review types available) need to take account of but frequently overlook. Our aim is to provide a typology of review types and describe key elements that need to be addressed during question development for each type.

Conclusions

In this paper a typology is proposed of various systematic review methodologies. The review types are defined and situated with regard to establishing corresponding questions and inclusion criteria. The ultimate objective is to provide clarified guidance for both novice and experienced reviewers and a unified typology with respect to review types.

Peer Review reports

Introduction

Systematic reviews are the gold standard to search for, collate, critique and summarize the best available evidence regarding a clinical question [1, 2]. The results of systematic reviews provide the most valid evidence base to inform the development of trustworthy clinical guidelines (and their recommendations) and clinical decision making [2]. They follow a structured research process that requires rigorous methods to ensure that the results are both reliable and meaningful to end users. Systematic reviews are therefore seen as the pillar of evidence-based healthcare [3,4,5,6]. However, systematic review methodology and the language used to express that methodology, has progressed significantly since their appearance in healthcare in the 1970’s and 80’s [7, 8]. The diachronic nature of this evolution has caused, and continues to cause, great confusion for both novice and experienced researchers seeking to synthesise various forms of evidence. Indeed, it has already been argued that the current proliferation of review types is creating challenges for the terminology for describing such reviews [9]. These fundamental issues primarily relate to a) the types of questions being asked and b) the types of evidence used to answer those questions.

Traditionally, systematic reviews have been predominantly conducted to assess the effectiveness of health interventions by critically examining and summarizing the results of randomized controlled trials (RCTs) (using meta-analysis where feasible) [4, 10]. However, health professionals are concerned with questions other than whether an intervention or therapy is effective, and this is reflected in the wide range of research approaches utilized in the health field to generate knowledge for practice. As such, Pearson and colleagues have argued for a pluralistic approach when considering what counts as evidence in health care; suggesting that not all questions can be answered from studies measuring effectiveness alone [4, 11]. As the methods to conduct systematic reviews have evolved and advanced, so too has the thinking around the types of questions we want and need to answer in order to provide the best possible, evidence-based care [4, 11].

Even though most systematic reviews conducted today still focus on questions relating to the effectiveness of medical interventions, many other review types which adhere to the principles and nomenclature of a systematic review have emerged to address the diverse information needs of healthcare professionals and policy makers. This increasing array of systematic review options may be confusing for the novice systematic reviewer, and in our experience as educators, peer reviewers and editors we find that many beginner reviewers struggle to achieve conceptual clarity when planning for a systematic review on an issue other than effectiveness. For example, reviewers regularly try to force their question into the PICO format (population, intervention, comparator and outcome), even though their question may be an issue of diagnostic test accuracy or prognosis; attempting to define all the elements of PICO can confound the remainder of the review process. The aim of this article is to propose a typology of systematic review types aligned to review questions to assist and guide the novice systematic reviewer and editors, peer-reviewers and policy makers. To our knowledge, this is the first classification of types of systematic reviews foci conducted in the medical and health sciences into one central typology.

Review typology

For the purpose of this typology a systematic review is defined as a robust, reproducible, structured critical synthesis of existing research. While other approaches to the synthesis of evidence exist (including but not limited to literature reviews, evidence maps, rapid reviews, integrative reviews, scoping and umbrella reviews), this paper seeks only to include approaches that subscribe to the above definition. As such, ten different types of systematic review foci are listed below and in Table 1. In this proposed typology, we provide the key elements for formulating a question for each of the 10 review types.

  1. 1.

    Effectiveness reviews [12]

  2. 2.

    Experiential (Qualitative) reviews [13]

  3. 3.

    Costs/Economic Evaluation reviews [14]

  4. 4.

    Prevalence and/or Incidence reviews [15]

  5. 5.

    Diagnostic Test Accuracy reviews [16]

  6. 6.

    Etiology and/or Risk reviews [17]

  7. 7.

    Expert opinion/policy reviews [18]

  8. 8.

    Psychometric reviews [19]

  9. 9.

    Prognostic reviews [20]

  10. 10.

    Methodological systematic reviews [21, 22]

Table 1 Types of reviews
Full size table

Effectiveness reviews

Systematic reviews assessing the effectiveness of an intervention or therapy are by far the most common. Essentially effectiveness is the extent to which an intervention, when used appropriately, achieves the intended effect [11]. The PICO approach (see Table 1) to question development is well known [23] and comprehensive guidance for these types of reviews is available [24]. Characteristics regarding the population (e.g. demographic and socioeconomic factors and setting), intervention (e.g. variations in dosage/intensity, delivery mode, and frequency/duration/timing of delivery), comparator (active or passive) and outcomes (primary and secondary including benefits and harms, how outcomes will be measured including the timing of measurement) need to be carefully considered and appropriately justified.

Experiential (qualitative) reviews

Experiential (qualitative) reviews focus on analyzing human experiences and cultural and social phenomena. Reviews including qualitative evidence may focus on the engagement between the participant and the intervention, as such a qualitative review may describe an intervention, but its question focuses on the perspective of the individuals experiencing it as part of a larger phenomenon. They can be important in exploring and explaining why interventions are or are not effective from a person-centered perspective. Similarly, this type of review can explain and explore why an intervention is not adopted in spite of evidence of its effectiveness [4, 13, 25]. They are important in providing information on the patient’s experience, which can enable the health professional to better understand and interact with patients. The mnemonic PICo can be used to guide question development (see Table 1). With qualitative evidence there is no outcome or comparator to be considered. A phenomenon of interest is the experience, event or process occurring that is under study, such as response to pain or coping with breast cancer; it differs from an intervention in its focus. Context will vary depending on the objective of the review; it may include consideration of cultural factors such as geographic location, specific racial or gender based interests, and details about the setting such as acute care, primary healthcare, or the community [4, 13, 25]. Reviews assessing the experience of a phenomenon may opt to use a mixed methods approach and also include quantitative data, such as that from surveys. There are reporting guidelines available for qualitative reviews, including the ‘Enhancing transparency in reporting the synthesis of qualitative research’ (ENTREQ) statement [26] and the newly proposed meta-ethnography reporting guidelines (eMERGe) [27].

Costs/economic evaluation reviews

Costs/Economics reviews assess the costs of a certain intervention, process, or procedure. In any society, resources available (including dollars) have alternative uses. In order to make the best decisions about alternative courses of action evidence is needed on the health benefits and also on the types and amount of resources needed for these courses of action. Health economic evaluations are particularly useful to inform health policy decisions attempting to achieve equality in healthcare provision to all members of society and are commonly used to justify the existence and development of health services, new health technologies and also, clinical guideline development [14]. Issues of cost and resource use may be standalone reviews or components of effectiveness reviews [28]. Cost/Economic evaluations are examples of a quantitative review and as such can follow the PICO mnemonic (see Table 1). Consideration should be given to whether the entire world/international population is to be considered or only a population (or sub-population) of a particular country. Details of the intervention and comparator should include the nature of services/care delivered, time period of delivery, dosage/intensity, co-interventions, and personnel undertaking delivery. Consider if outcomes will only focus on resource usage and costs of the intervention and its comparator(s) or additionally on cost-effectiveness. Context (including perspective) can also be considered in these types of questions e.g. health setting(s).

Prevalence and/or incidence reviews

Essentially prevalence or incidence reviews measure disease burden (whether at a local, national or global level). Prevalence refers to the proportion of a population who have a certain disease whereas incidence relates to how often a disease occurs. These types of reviews enable governments, policy makers, health professionals and the general population to inform the development and delivery of health services and evaluate changes and trends in diseases over time [15, 29]. Prevalence or incidence reviews are important in the description of geographical distribution of a variable and the variation between subgroups (such as gender or socioeconomic status), and for informing health care planning and resource allocation. The CoCoPop framework can be used for reviews addressing a question relevant to prevalence or incidence (see Table 1). Condition refers to the variable of interest and can be a health condition, disease, symptom, event of factor. Information regarding how the condition will be measured, diagnosed or confirmed should be provided. Environmental factors can have a substantial impact on the prevalence or incidence of a condition so it is important that authors define the context or specific setting relevant to their review question [15, 29]. The population or study subjects should be clearly defined and described in detail.

Diagnostic test accuracy reviews

Systematic reviews assessing diagnostic test accuracy provide a summary of test performance and are important for clinicians and other healthcare practitioners in order to determine the accuracy of the diagnostic tests they use or are considering using [16]. Diagnostic tests are used by clinicians to identify the presence or absence of a condition in a patient for the purpose of developing an appropriate treatment plan. Often there are several tests available for diagnosis. The mnemonic PIRD is recommended for question development for these types of systematic reviews (see Table 1). The population is all participants who will undergo the diagnostic test while the index test(s) is the diagnostic test whose accuracy is being investigated in the review. Consider if multiple iterations of a test exist and who carries out or interprets the test, the conditions the test is conducted under and specific details regarding how the test will be conducted. The reference test is the ‘gold standard’ test to which the results of the index test will be compared. It should be the best test currently available for the diagnosis of the condition of interest. Diagnosis of interest relates to what diagnosis is being investigated in the systematic review. This may be a disease, injury, disability or any other pathological condition [16].

Etiology and/or risk reviews

Systematic reviews of etiology and risk are important for informing healthcare planning and resource allocation, and are particularly valuable for decision makers when making decisions regarding health policy and prevention of adverse health outcomes. The common objective of many of these types of reviews is to determine whether and to what degree a relationship exists between an exposure and a health outcome. Use of the PEO mnemonic is recommended (see Table 1). The review question should outline the exposure, disease, symptom or health condition of interest, the population or groups at risk, as well as the context/location, the time period and the length of time where relevant [17]. The exposure of interest refers to a particular risk factor or several risk factors associated with a disease/condition of interest in a population, group or cohort who have been exposed to them. It should be clearly reported what the exposure or risk factor is, and how it may be measured/identified including the dose and nature of exposure and the duration of exposure, if relevant. Important outcomes of interest relevant to the health issue and important to key stakeholders (e.g. knowledge users, consumers, policy makers, payers etc.) must be specified. Guidance now exists for conducting these types of reviews [17]. As these reviews rely heavily on observational studies, the Meta-analysis Of Observational Studies in Epidemiology (MOOSE) [30] reporting guidelines should be referred to in addition to the PRISMA guidelines.

Expert opinion/policy reviews

Expert opinion and policy analysis systematic reviews focus on the synthesis of narrative text and/or policy. Expert opinion has a role to play in evidence-based healthcare, as it can be used to either complement empirical evidence or, in the absence of research studies, stand alone as the best available evidence. The synthesis of findings from expert opinion within the systematic review process is not well recognized in mainstream evidence-based practice. However, in the absence of research studies, the use of a transparent systematic process to identify the best available evidence drawn from text and opinion can provide practical guidance to practitioners and policy makers [18]. While a number of mnemonics have been discussed previously that can be used for opinion and text, not all elements necessarily apply to every text or opinion-based review, and use of mnemonics should be considered a guide rather than a policy. Broadly PICo can be used where I can refer to either the intervention or a phenomena of interest (see Table 1). Reviewers will need to describe the population, giving attention to whether specific characteristics of interest, such as age, gender, level of education or professional qualification are important to the question. As with other types of reviews, interventions may be broad areas of practice management, or specific, singular interventions. However, reviews of text or opinion may also reflect an interest in opinions around power, politics or other aspects of health care other than direct interventions, in which case, these should be described in detail. The use of a comparator and specific outcome statement is not necessarily required for a review of text and opinion based literature. In circumstances where they are considered appropriate, the nature and characteristics of the comparator and outcomes should be described [18].

Psychometric reviews

Psychometric systematic reviews (or systematic reviews of measurement properties) are conducted to assess the quality/characteristics of health measurement instruments to determine the best tool for use (in terms of its validity, reliability, responsiveness etc.) in practice for a certain condition or factor [31,32,33]. A psychometric systematic review may be undertaken on a) the measurement properties of one measurement instrument, b) the measurement properties of the most commonly utilized measurement instruments measuring a specific construct, c) the measurement properties of all available measurement instruments to measure a specific construct in a specific population or d) the measurement properties of all available measurement instruments in a specific population that does not specify the construct to be measured. The COnsensus-based Standards for the selection of health Measurement Instruments (COSMIN) group have developed guidance for conducting these types of reviews [19, 31]. They recommend firstly defining the type of review to be conducted as well as the construct or the name(s) of the outcome measurement instrument(s) of interest, the target population, the type of measurement instrument of interest (e.g. questionnaires, imaging tests) and the measurement properties on which the review investigates (see Table 1).

Prognostic reviews

Prognostic research is of high value as it provides clinicians and patients with information regarding the course of a disease and potential outcomes, in addition to potentially providing useful information to deliver targeted therapy relating to specific prognostic factors [20, 34, 35]. Prognostic reviews are complex and methodology for these types of reviews is still under development, although a Cochrane methods group exists to support this approach [20]. Potential systematic reviewers wishing to conduct a prognostic review may be interested in determining the overall prognosis for a condition, the link between specific prognostic factors and an outcome and/or prognostic/prediction models and prognostic tests [20, 34,35,36,37]. Currently there is little information available to guide the development of a well-defined review question however the Quality in Prognosis Studies (QUIPS) tool [34] and the Checklist for critical appraisal and data extraction for systematic reviews of prediction modelling studies (CHARMS Checklist) [38] have been developed to assist in this process (see Table 1).

Methodology systematic reviews

Systematic reviews can be conducted for methodological purposes [39], and examples of these reviews are available in the Cochrane Database [40, 41] and elsewhere [21]. These reviews can be performed to examine any methodological issues relating to the design, conduct and review of research studies and also evidence syntheses. There is limited guidance for conducting these reviews, although there does exist an appendix in the Cochrane Handbook focusing specifically on methodological reviews [39]. They suggest following the SDMO approach where the types of studies should define all eligible study designs as well as any thresholds for inclusion (e.g. RCTS and quasi-RCTs). Types of data should detail the raw material for the methodology studies (e.g. original research submitted to biomedical journals) and the comparisons of interest should be described under types of methods (e.g. blinded peer review versus unblinded peer review) (see Table 1). Lastly both primary and secondary outcome measures should be listed (e.g. quality of published report) [39].

Discussion

The need to establish a specific, focussed question that can be utilized to define search terms, inclusion and exclusion criteria and interpretation of data within a systematic review is an ongoing issue [42]. This paper provides an up-to-date typology for systematic reviews which reflects the current state of systematic review conduct. It is now possible that almost any question can be subjected to the process of systematic review. However, it can be daunting and difficult for the novice researcher to determine what type of review they require and how they should conceptualize and phrase their review question, inclusion criteria and the appropriate methods for analysis and synthesis [23]. Ensuring that the review question is well formed is of the utmost importance as question design has the most significant impact on the conduct of a systematic review as the subsequent inclusion criteria are drawn from the question and provide the operational framework for the review [23]. In this proposed typology, we provide the key elements for formulating a question for each of the 10 review types.

When structuring a systematic review question some of these key elements are universally agreed (such as PICO for effectiveness reviews) whilst others are more novel. For example, the use of PIRD for diagnostic reviews contrasts with other mnemonics, such as PITR [43], PPP-ICP-TR [44] or PIRATE [45]. Qualitative reviews have sometimes been guided by the mnemonic SPIDER, however this has been recommended against for guiding searching due to it not identifying papers that are relevant [46]. Variations on our guidance exist, with the additional question elements of ‘time’ (PICOT) and study types (PICOS) also existing. Reviewers are advised to consider these elements when crafting their question to determine if they are relevant for their topic. We believe that based on the guidance included in this typology, constructing a well-built question for a systematic review is a skill that can be mastered even for the novice reviewer.

Related to this discussion of a typology for systematic reviews is the issue of how to distinguish a systematic review from a literature review. When searching the literature, you may come across papers referred to as ‘systematic reviews,’ however, in reality they do not necessarily fit this description [21]. This is of significant concern given the common acceptance of systematic reviews as ‘level 1’ evidence and the best study design to inform practice. However, many of these reviews are simply literature reviews masquerading as the ideal product. It is therefore important to have a critical eye when assessing publications identified as systematic reviews. Today, the methodology of systematic reviews continues to evolve. However, there is general acceptance of certain steps being required in a systematic review of any evidence type [2] and these should be used to distinguish between a literature review and a systematic review. The following can be viewed as the defining features of a systematic review and its conduct [1, 2]:

  1. 1.

    Clearly articulated objectives and questions to be addressed

  2. 2.

    Inclusion and exclusion criteria, stipulated a priori (in a protocol), that determine the eligibility of studies

  3. 3.

    A comprehensive search to identify all relevant studies, both published and unpublished

  4. 4.

    A process of study screening and selection

  5. 5.

    Appraisal of the quality of included studies/ papers (risk of bias) and assessment of the validity of their results/findings/ conclusions

  6. 6.

    Analysis of data extracted from the included research

  7. 7.

    Presentation and synthesis of the results/ findings extracted

  8. 8.

    Interpret the results, potentially establishing the certainty of the results and making and implications for practice and research

  9. 9.

    Transparent reporting of the methodology and methods used to conduct the review

Prior to deciding what type of review to conduct, the reviewer should be clear that a systematic review is the best approach. A systematic review may be undertaken to confirm whether current practice is based on evidence (or not) and to address any uncertainty or variation in practice that may be occurring. Conducting a systematic review also identifies where evidence is not available and can help categorize future research in the area. Most importantly, they are used to produce statements to guide decision-making. Indications for systematic reviews:

  1. 1.

    uncover the international evidence

  2. 2.

    confirm current practice/ address any variation

  3. 3.

    identify areas for future research

  4. 4.

    investigate conflicting results

  5. 5.

    produce statements to guide decision-making

The popularity of systematic reviews has resulted in the creation of various evidence review processes over the last 30 years. These include integrative reviews, scoping reviews [47], evidence maps [48], realist syntheses [49], rapid reviews [50], umbrella reviews (systematic reviews of reviews) [51], mixed methods reviews [52], concept analyses [53] and others. Useful typologies of these diverse review types can be used as reference for researchers, policy makers and funders when discussing a review approach [54, 55]. It was not the purpose of this article to describe and define each of these diverse evidence synthesis methods as our focus was purely on systematic review questions. Depending on the researcher, their question/s and their resources at hand, one of these approaches may be the best fit for answering a particular question.

Gough and colleagues [9] provided clarification between different review designs and methods but stopped short of providing a taxonomy of review types. The rationale for this was that in the field of evidence synthesis ‘the rate of development of new approaches to reviewing is too fast and the overlap of approaches too great for that to be helpful.’ [9] They instead provide a useful description of how reviews may differ and more importantly why this may be the case. It is also our view that evidence synthesis methodology is a rapidly developing field, and that even within the review types classified here (such as effectiveness [56] or experiential [qualitative [57]]) there may be many different subsets and complexities that need to be addressed. Essentially, the classifications listed above may be just the initial level of a much larger family tree. We believe that this typology will provide a useful contribution to efforts to sort and classify evidence review approaches and understand the need for this to be updated over time. A useful next step might be the development of a comprehensive taxonomy to further guide reviewers in making a determination about the most appropriate evidence synthesis product to undertake for a particular purpose or question.

Systematic reviews of animal studies (or preclinical systematic reviews) have not been common practice in the past (when comparing to clinical research) although this is changing [58,59,60,61]. Systematic reviews of these types of studies can be useful to inform the design of future experiments (both preclinical and clinical) [59] and address an important gap in translation science [5, 60]. Guidance for these types of reviews is now emerging [58, 60, 62,63,64]. These review types, which are often hypothesis generating, were excluded from our typology as they are only very rarely used to answer a clinical question.

Systematic reviews are clearly an indispensable component in the chain of scientific enquiry in a much broader sense than simply to inform policy and practice and therefore ensuring that they are designed in a rigorous manner, addressing appropriate questions driven by clinical and policy needs is essential. With the ever-increasing global investment in health research it is imperative that the needs of health service providers and end users are met. It has been suggested that one way to ensure this occurs is to precede any research investment with a systematic review of existing research [65]. However, the only way that such a strategy would be effective would be if all reviews conducted are done so with due rigour.

It has been argued recently that there is mass production of reviews that are often unnecessary, misleading and conflicted with most having weak or insufficient evidence to inform decision making [66]. Indeed, asking has been identified as a core functional competency associated with obtaining and applying the best available evidence [67]. Fundamental to the tenets of evidence-based healthcare and, in particular evidence implementation, is the ability to formulate a question that is amenable to obtaining evidence and “structured thinking” around question development is critical to its success [67]. The application of evidence can be significantly hampered when existing evidence does not correspond to the situations that practitioners (or guideline developers) are faced with. Hence, determination of appropriate review types that respond to relevant clinical and policy questions is essential.

The revised JBI Model of Evidence-Based Healthcare clarifies the conceptual integration of evidence generation, synthesis, transfer and implementation, “linking how these occur with the necessarily challenging dynamics that contribute to whether translation of evidence into policy and practice is successful” [68]. Fundamental to this approach is the recognition that the process of evidence-based healthcare is not prescriptive or linear, but bi-directional, with each component having the potential to affect what occurs on either side of it. Thus, a systematic review can impact upon the types of primary research that are generated as a result of recommendations produced in the review (evidence generation) but also on the success of their uptake in policy and practice (evidence implementation). It is therefore critical for those undertaking systematic reviews to have a solid understanding of the type of review required to respond to their question.

For novice reviewers, or those unfamiliar with the broad range of review types now available, access to a typology to inform their question development is timely. The typology described above provides a framework that indicates the antecedents and determinants of undertaking a systematic review. There are several factors that may lead an author to conduct a review and these may or may not start with a clearly articulated clinical or policy question. Having a better understanding of the review types available and the questions that these reviews types lend themselves to answering is critical to the success or otherwise of a review. Given the significant resource required to undertake a review this first step is critical as it will impact upon what occurs in both evidence generation and evidence implementation. Thus, enabling novice and experienced reviewers to ensure that they are undertaking the “right” review to respond to a clinical or policy question appropriately has strategic implications from a broader evidence-based healthcare perspective.

Conclusion

Systematic reviews are the ideal method to rigorously collate, examine and synthesize a body of literature. Systematic review methods now exist for most questions that may arise in healthcare. This article provides a typology for systematic reviewers when deciding on their approach in addition to guidance on structuring their review question. This proposed typology provides the first known attempt to sort and classify systematic review types and their question development frameworks and therefore it can be a useful tool for researchers, policy makers and funders when deciding on an appropriate approach.

Abbreviations

CHARMS:

CHecklist for critical Appraisal and data extraction for systematic Reviews of prediction Modelling Studies

CoCoPop:

Condition, Context, Population

COSMIN:

COnsensus-based Standards for the selection of health Measurement Instruments

EBHC:

Evidence-based healthcare

eMERGe:

Meta-ethnography reporting guidelines

ENTREQ:

Enhancing transparency in reporting the synthesis of qualitative research

JBI:

Joanna Briggs Institute

MOOSE:

Meta-analysis Of Observational Studies in Epidemiology

PEO:

Population, Exposure, Outcome

PFO:

Population, Prognostic Factors (or models of interest), Outcome

PICO:

Population, Intervention, Comparator, Outcome

PICo:

Population, Phenomena of Interest, Context

PICOC:

Population, Intervention, Comparator/s, Outcomes, Context

PIRD:

Population, Index Test, Reference Test, Diagnosis of Interest

QUIPS:

Quality in Prognosis Studies

RCT:

Randomised controlled trial

SDMO:

Studies, Data, Methods, Outcomes

References

  1. 1.

    Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (Clinical research ed). 2009;339:b2700.

  2. 2.

    Aromataris E, Pearson A. The systematic review: an overview. AJN. Am J Nurs. 2014;114(3):53–8.

  3. 3.

    Munn Z, Porritt K, Lockwood C, Aromataris E, Pearson A. Establishing confidence in the output of qualitative research synthesis: the ConQual approach. BMC Med Res Methodol. 2014;14:108.

  4. 4.

    Pearson A. Balancing the evidence: incorporating the synthesis of qualitative data into systematic reviews. JBI Reports. 2004;2:45–64.

  5. 5.

    Pearson A, Jordan Z, Munn Z. Translational science and evidence-based healthcare: a clarification and reconceptualization of how knowledge is generated and used in healthcare. Nursing research and practice. 2012;2012:792519.

  6. 6.

    Steinberg E, Greenfield S, Mancher M, Wolman DM, Graham R. Clinical practice guidelines we can trust: National Academies Press 2011.

  7. 7.

    Bastian H, Glasziou P, Chalmers I. Seventy-five trials and eleven systematic reviews a day: how will we ever keep up? PLoS Med. 2010;7(9):e1000326.

  8. 8.

    Chalmers I, Hedges LV, Cooper HA. Brief history of research synthesis. Eval Health Prof. 2002;25(1):12–37.

  9. 9.

    Gough D, Thomas J, Oliver S. Clarifying differences between review designs and methods. Systematic Reviews. 2012;1:28.

  10. 10.

    Munn Z, Tufanaru C, Aromataris EJBI. S systematic reviews: data extraction and synthesis. Am J Nurs. 2014;114(7):49–54.

  11. 11.

    Pearson A, Wiechula R, Court A, Lockwood C. The JBI model of evidence-based healthcare. International Journal of Evidence-Based Healthcare. 2005;3(8):207–15.

  12. 12.

    Tufanaru C, Munn Z, Stephenson M, Aromataris E. Fixed or random effects meta-analysis? Common methodological issues in systematic reviews of effectiveness. Int J Evid Based Healthc. 2015;13(3):196–207.

  13. 13.

    Lockwood C, Munn Z, Porritt K. Qualitative research synthesis: methodological guidance for systematic reviewers utilizing meta-aggregation. Int J Evid Based Healthc. 2015;13(3):179–87.

  14. 14.

    Gomersall JS, Jadotte YT, Xue Y, Lockwood S, Riddle D, Preda A. Conducting systematic reviews of economic evaluations. Int J Evid Based Healthc. 2015;13(3):170–8.

  15. 15.

    Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int J Evid Based Healthc. 2015;13(3):147–53.

  16. 16.

    Campbell JM, Klugar M, Ding S, et al. Diagnostic test accuracy: methods for systematic review and meta-analysis. Int J Evid Based Healthc. 2015;13(3):154–62.

  17. 17.

    Moola S, Munn Z, Sears K, et al. Conducting systematic reviews of association (etiology): the Joanna Briggs Institute's approach. Int J Evid Based Healthc. 2015;13(3):163–9.

  18. 18.

    McArthur A, Klugarova J, Yan H, Florescu S. Innovations in the systematic review of text and opinion. Int J Evid Based Healthc. 2015;13(3):188–95.

  19. 19.

    Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res. 2010;19(4):539–49.

  20. 20.

    Dretzke J, Ensor J, Bayliss S, et al. Methodological issues and recommendations for systematic reviews of prognostic studies: an example from cardiovascular disease. Systematic reviews. 2014;3(1):1.

  21. 21.

    Campbell JM, Kavanagh S, Kurmis R, Munn Z. Systematic Reviews in Burns Care: Poor Quality and Getting Worse. Journal of Burn Care & Research. 9000;Publish Ahead of Print.

  22. 22.

    France EF, Ring N, Thomas R, Noyes J, Maxwell M, Jepson RA. Methodological systematic review of what’s wrong with meta-ethnography reporting. BMC Med Res Methodol. 2014;14(1):1.

  23. 23.

    Stern C, Jordan Z, McArthur A. Developing the review question and inclusion criteria. Am J Nurs. 2014;114(4):53–6.

  24. 24.

    Higgins J, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. ed: The Cochrane Collaboration 2011.

  25. 25.

    Hannes K, Lockwood C, Pearson AA. Comparative analysis of three online appraisal instruments' ability to assess validity in qualitative research. Qual Health Res. 2010;20(12):1736–43.

  26. 26.

    Tong A, Flemming K, McInnes E, Oliver S, Craig J. Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ. BMC Med Res Methodol. 2012;12:181.

  27. 27.

    France EF, Ring N, Noyes J, et al. Protocol-developing meta-ethnography reporting guidelines (eMERGe). BMC Med Res Methodol. 2015;15:103.

  28. 28.

    Shemilt I, Mugford M, Byford S, et al. In: JPT H, Green S, editors. Chapter 15: incorporating economics evidence. Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration: In; 2011.

  29. 29.

    Munn Z, Moola S, Riitano D, Lisy K. The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence. Int J Health Policy Manag. 2014;3(3):123–8.

  30. 30.

    Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–12.

  31. 31.

    COSMIN: COnsensus-based Standards for the selection of health Measurement INstruments. Systematic reviews of measurement properties. [cited 8th December 2016]; Available from: http://www.cosmin.nl/Systematic%20reviews%20of%20measurement%20properties.html

  32. 32.

    Terwee CB, HCWd V, CAC P, Mokkink LB. Protocol for systematic reviews of measurement properties. COSMIN: Knowledgecenter Measurement Instruments; 2011.

  33. 33.

    Mokkink LB, Terwee CB, Stratford PW, et al. Evaluation of the methodological quality of systematic reviews of health status measurement instruments. Qual Life Res. 2009;18(3):313–33.

  34. 34.

    Hayden JA, van der Windt DA, Cartwright JL, CÃ P, Bombardier C. Assessing bias in studies of prognostic factors. Ann Intern Med. 2013;158(4):280–6.

  35. 35.

    The Cochrane Collaboration. Cochrane Methods Prognosis. 2016 [cited 7th December 2016]; Available from: http://methods.cochrane.org/prognosis/scope-our-work.

  36. 36.

    Rector TS, Taylor BC, Wilt TJ. Chapter 12: systematic review of prognostic tests. J Gen Intern Med. 2012;27(Suppl 1):S94–101.

  37. 37.

    Peters S, Johnston V, Hines S, Ross M, Coppieters M. Prognostic factors for return-to-work following surgery for carpal tunnel syndrome: a systematic review. JBI Database of Systematic Reviews and Implementation Reports. 2016;14(9):135–216.

  38. 38.

    Moons KG, de Groot JA, Bouwmeester W, et al. Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist. PLoS Med. 2014;11(10):e1001744.

  39. 39.

    Clarke M, Oxman AD, Paulsen E, Higgins JP, Green S, Appendix A: Guide to the contents of a Cochrane Methodology protocol and review. In: Higgins JP, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 ed: The Cochrane Collaboration 2011.

  40. 40.

    Jefferson T, Rudin M, Brodney Folse S, Davidoff F. Editorial peer review for improving the quality of reports of biomedical studies. Cochrane Database Syst Rev. 2007;2:MR000016.

  41. 41.

    Djulbegovic B, Kumar A, Glasziou PP, et al. New treatments compared to established treatments in randomized trials. Cochrane Database Syst Rev. 2012;10:MR000024.

  42. 42.

    Thoma A, Eaves FF 3rd. What is wrong with systematic reviews and meta-analyses: if you want the right answer, ask the right question! Aesthet Surg J. 2016;36(10):1198–201.

  43. 43.

    Deeks JJ, Wisniewski S, Davenport C. In: Deeks JJ, Bossuyt PM, Gatsonis C, editors. Chapter 4: guide to the contents of a Cochrane diagnostic test accuracy protocol. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy The Cochrane Collaboration: In; 2013.

  44. 44.

    Bae J-M. An overview of systematic reviews of diagnostic tests accuracy. Epidemiology and Health. 2014;36:e2014016.

  45. 45.

    White S, Schultz T. Enuameh YAK. Lippincott Wiliams & Wilkins: Synthesizing evidence of diagnostic accuracy; 2011.

  46. 46.

    Methley AM, Campbell S, Chew-Graham C, McNally R, Cheraghi-Sohi SPICO. PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews. BMC Health Serv Res. 2014;14:579.

  47. 47.

    Peters MD, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting systematic scoping reviews. International journal of evidence-based healthcare. 2015;13(3):141–6.

  48. 48.

    Hetrick SE, Parker AG, Callahan P, Purcell R. Evidence mapping: illustrating an emerging methodology to improve evidence-based practice in youth mental health. J Eval Clin Pract. 2010;16(6):1025–30.

  49. 49.

    Wong G, Greenhalgh T, Westhorp G, Pawson R. Development of methodological guidance, publication standards and training materials for realist and meta-narrative reviews: the RAMESES (Realist And Meta-narrative Evidence Syntheses - Evolving Standards) project. Southampton UK: Queen's Printer and Controller of HMSO 2014. This work was produced by Wong et al. under the terms of a commissioning contract issued by the secretary of state for health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR journals library, National Institute for Health Research, evaluation, trials and studies coordinating Centre, alpha house, University of Southampton Science Park, Southampton SO16 7NS, UK. 2014.

  50. 50.

    Munn Z, Lockwood C, Moola S. The development and use of evidence summaries for point of care information systems: a streamlined rapid review approach. Worldviews Evid-Based Nurs. 2015;12(3):131–8.

  51. 51.

    Aromataris E, Fernandez R, Godfrey CM, Holly C, Khalil H, Tungpunkom P. Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. Int J Evid Based Healthc. 2015;13(3):132–40.

  52. 52.

    Pearson A, White H, Bath-Hextall F, Salmond S, Apostolo J, Kirkpatrick PA. Mixed-methods approach to systematic reviews. Int J Evid Based Healthc. 2015;13(3):121–31.

  53. 53.

    Draper PA. Critique of concept analysis. J Adv Nurs. 2014;70(6):1207–8.

  54. 54.

    Grant MJ, Booth A. A Typology of reviews: an analysis of 14 review types and associated methodologies. Health Inf Libr J. 2009;26(2):91–108.

  55. 55.

    Tricco AC, Tetzlaff J, Moher D. The art and science of knowledge synthesis. J Clin Epidemiol. 2011;64(1):11–20.

  56. 56.

    Bender R. A practical taxonomy proposal for systematic reviews of therapeutic interventions. 21st Cochrane Colloquium Quebec, Canada 2013.

  57. 57.

    Kastner M, Tricco AC, Soobiah C, et al. What is the most appropriate knowledge synthesis method to conduct a review? Protocol for a scoping review. BMC Med Res Methodol. 2012;12:114.

  58. 58.

    Leenaars M, Hooijmans CR, van Veggel N, et al. A step-by-step guide to systematically identify all relevant animal studies. Lab Anim. 2012;46(1):24–31.

  59. 59.

    de Vries RB, Wever KE, Avey MT, Stephens ML, Sena ES, Leenaars M. The usefulness of systematic reviews of animal experiments for the design of preclinical and clinical studies. ILAR J. 2014;55(3):427–37.

  60. 60.

    Hooijmans CR, Ritskes-Hoitinga M. Progress in using systematic reviews of animal studies to improve translational research. PLoS Med. 2013;10(7):e1001482.

  61. 61.

    Mignini LE, Khan KS. Methodological quality of systematic reviews of animal studies: a survey of reviews of basic research. BMC Med Res Methodol. 2006;6:10.

  62. 62.

    van Luijk J, Bakker B, Rovers MM, Ritskes-Hoitinga M, de Vries RB, Leenaars M. Systematic reviews of animal studies; missing link in translational research? PLoS One. 2014;9(3):e89981.

  63. 63.

    Vesterinen HM, Sena ES, Egan KJ, et al. Meta-analysis of data from animal studies: a practical guide. J Neurosci Methods. 2014;221:92–102.

  64. 64.

    CAMARADES. Collaborative Approach to Meta-Analysis and Review of Animal Data from Experimental Studies. 2014 [cited 8th December 2016]; Available from: http://www.dcn.ed.ac.uk/camarades/default.htm#about

  65. 65.

    Moher D, Glasziou P, Chalmers I, et al. Increasing value and reducing waste in biomedical research: who's listening? Lancet. 2016;387(10027):1573–86.

  66. 66.

    Ioannidis J. The mass production of redundant, misleading, and conflicted systematic reviews and meta-analyses. The Milbank Quarterly. 2016;94(3):485–514.

  67. 67.

    Rousseau DM, Gunia BC. Evidence-based practice: the psychology of EBP implementation. Annu Rev Psychol. 2016;67:667–92.

  68. 68.

    Jordan Z, Lockwood C, Aromataris E. Munn Z. The Joanna Briggs Institute: The updated JBI model for evidence-based healthcare; 2016.

  69. 69.

    Cooney GM, Dwan K, Greig CA, et al. Exercise for depression. Cochrane Database Syst Rev. 2013;9:CD004366.

  70. 70.

    Munn Z, Jordan Z. The patient experience of high technology medical imaging: a systematic review of the qualitative evidence. JBI Libr. Syst Rev. 2011;9(19):631–78.

  71. 71.

    de Verteuil R, Tan WS. Self-monitoring of blood glucose in type 2 diabetes mellitus: systematic review of economic evidence. JBI Libr. Syst Rev. 2010;8(7):302–42.

  72. 72.

    Munn Z, Moola S, Lisy K, Riitano D, Murphy F. Claustrophobia in magnetic resonance imaging: a systematic review and meta-analysis. Radiography. 2015;21(2):e59–63.

  73. 73.

    Hakonsen SJ, Pedersen PU, Bath-Hextall F, Kirkpatrick P. Diagnostic test accuracy of nutritional tools used to identify undernutrition in patients with colorectal cancer: a systematic review. JBI Database System Rev Implement Rep. 2015;13(4):141–87.

  74. 74.

    Australia C. Risk factors for lung cancer: a systematic review. NSW: Surry Hills; 2014.

  75. 75.

    McArthur A, Lockwood C. Maternal mortality in Cambodia, Thailand, Malaysia and Sri Lanka: a systematic review of local and national policy and practice initiatives. JBI Libr Syst Rev. 2010;8(16 Suppl):1–10.

  76. 76.

    Peek K. Muscle strength in adults with spinal cord injury: a systematic review of manual muscle testing, isokinetic and hand held dynamometry clinimetrics. JBI Database of Systematic Reviews and Implementation Reports. 2014;12(5):349–429.

  77. 77.

    Hayden JA, Tougas ME, Riley R, Iles R, Pincus T. Individual recovery expectations and prognosis of outcomes in non-specific low back pain: prognostic factor exemplar review. Cochrane Libr. 2014. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD011284/full.

Download references

Acknowledgements

None

Funding

No funding was provided for this paper.

Availability of data and materials

Not applicable

Author information

Affiliations

  1. The Joanna Briggs Institute, The University of Adelaide, 55 King William Road, North Adelaide, Soueth Australia, 5005, Australia
    • Zachary Munn
    • , Cindy Stern
    • , Edoardo Aromataris
    • , Craig Lockwood
    •  & Zoe Jordan
Authors
  1. Zachary Munn
    View author publications
    You can also search for this author in
  2. Cindy Stern
    View author publications
    You can also search for this author in
  3. Edoardo Aromataris
    View author publications
    You can also search for this author in
  4. Craig Lockwood
    View author publications
    You can also search for this author in
  5. Zoe Jordan
    View author publications
    You can also search for this author in

Contributions

ZM: Led the development of this paper and conceptualised the idea for a systematic review typology. Provided final approval for submission. CS: Contributed conceptually to the paper and wrote sections of the paper. Provided final approval for submission. EA: Contributed conceptually to the paper and reviewed and provided feedback on all drafts. Provided final approval for submission. CL: Contributed conceptually to the paper and reviewed and provided feedback on all drafts. Provided final approval for submission. ZJ: Contributed conceptually to the paper and reviewed and provided feedback on all drafts. Provided approval and encouragement for the work to proceed. Provided final approval for submission.

Corresponding author

Correspondence to Zachary Munn.

Ethics declarations

Ethics approval and consent to participate

Not applicable

Consent for publication

Not applicable

Competing interests

All the authors are members of the Joanna Briggs Institute, an evidence-based healthcare research institute which provides formal guidance regarding evidence synthesis, transfer and implementation.

The authors have no other competing interests to declare.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Munn, Z., Stern, C., Aromataris, E. et al. What kind of systematic review should I conduct? A proposed typology and guidance for systematic reviewers in the medical and health sciences. BMC Med Res Methodol 18, 5 (2018). https://doi.org/10.1186/s12874-017-0468-4

Download citation

Keywords

  • Systematic reviews
  • Evidence-based healthcare
  • Question development

BMC Medical Research Methodology

ISSN: 1471-2288

Contact us